,21 To further validate its clinical relevance, the authors analyzed cholangiocarcinoma data from the GEPIA2 database, which revealed significant ALYREF upregulation in tumor tissues compared to normal controls (Supplementary Fig. 2A), consistent with its established oncogenic role across multiple cancer types. The gene discussed is ALYREF; the disease is cholangiocarcinoma.